OrbiMed Israel Partners II, L.P.

Insider profile

OrbiMed Israel Partners II, L.P.'s trades of Adicet Bio Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-08 2026-04-08 PrS Proposed sale
90,401
65.66
US$1,877,285
90,401 65.66 US$1,877,285
2023-10-02 2023-10-02 PrS Proposed sale
84,672
50.00
US$184,690
84,672 50.00 US$184,690
2023-08-30 2023-08-30 PrS Proposed sale
18,725
223.45
US$328,036
18,725 223.45 US$328,036
2023-08-21 2023-08-21 PrS Proposed sale
631,048
0.62
US$389,357
631,048 0.62 US$389,357
2023-08-15 2023-08-15 PrS Proposed sale
489,970
0.75
US$367,478
489,970 0.75 US$367,478
2023-07-31 2023-07-31 PrS Proposed sale
180,300
3.02
US$544,506
180,300 3.02 US$544,506
2023-07-25 2023-07-25 PrS Proposed sale
4,700
2.35
US$11,045
4,700 2.35 US$11,045
2023-07-13 2023-07-13 PrS Proposed sale
52,800
2.55
US$134,640
52,800 2.55 US$134,640
2023-04-10 2023-04-10 PrS Proposed sale
9,064
1.90
US$17,222
9,064 1.90 US$17,222
2023-04-05 2023-04-05 PrS Proposed sale
43,810
2.24
US$97,915
43,810 2.24 US$97,915